Analytical Data
-
Gene name
THYN1
- Application
-
Alternative Names
THYN1；THY28；Thymocyte nuclear Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9P016
-
Expression Region
1-225aa
-
AA Sequence
MSRPRKRLAG TSGSDKGLSG KRTKTENSGE ALAKVEDSNP QKTSATKNCL KNLSSHWLMK SEPESRLEKG VDVKFSIEDL KAQPKQTTCW DGVRNYQARN FLRAMKLGEE AFFYHSNCKE PGIAGLMKIV KEAYPDHTQF EKNNPHYDPS SKEDNPKWSM VDVQFVRMMK RFIPLAELKS YHQAHKATGG PLKNMVLFTR QRLSIQPLTQ EEFDFVLSLE EKEPS
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
THYN1, known as T-Homologous protein 1, is a protein that has garnered significant attention in the field of molecular biology and biomedicine due to its intriguing role in various cellular processes. Originally identified in studies focusing on the regulation of gene expression and cellular stress responses, THYN1 is believed to be involved in the modulation of apoptosis and cellular differentiation, making it a potential target for therapeutic interventions. Research has shown that THYN1 can interact with various signaling pathways, influencing the proliferation and survival of cells under stress conditions. Additionally, aberrations in THYN1 expression have been linked to several diseases, including cancer, where its dysregulation may contribute to tumor progression and metastasis. The production of recombinant THYN1 protein has facilitated in-depth studies into its functional mechanisms, enabling researchers to elucidate its biological roles and potential as a biomarker or therapeutic target. By employing advanced techniques such as CRISPR-Cas9 gene editing and proteomics, recent studies aim to clarify how THYN1 affects cell fate decisions, providing insights into the fundamental processes of life and disease. Overall, the investigation of THYN1 not only enhances our understanding of cellular biology but also opens new avenues for the development of innovative treatment strategies for various diseases.
